"Dead Man Walking": der "Fememörder" Paul Schulz und seine "Erschießung am 30. Juni 1934"

'Am 30. Juni 1934 ('Röhm-Putsch') versuchte die NS-Führung, sich auch des 'Fememörders' Paul Schulz zu entledigen, obwohl sie ihn nur wenige Jahre zuvor mit aufwändigen Kampagnen zum 'Helden' stilisiert hatte. Denn nachdem Schulz von einem republikanischen Gericht wegen Mordes an den 'Verrätern' in den Reihen der 'Schwarzen Reichswehr' zum Tode verurteilt worden war, wurde er 1927 vorzeitig in den 'Kult um die toten Helden' der nationalsozialistischen 'Bewegung' aufgenommen. 1930 jedoch wurde er amnestiert und musste als nun wieder lebendiger 'toter Held' in die NSDAP (re)integriert werden. Der Beitrag untersucht, wie von hier an der Schulz-Mythos ein bemerkenswertes, den Nationalsozialisten bedrohlich werdendes Eigenleben entwickelte. Das Interesse gilt im Folgenden vor allem zwei Aspekten: 1. den 'Femeprozessen' und der Frage, wem und aus welchen Gründen die vermeintliche Leiche ikonisch (1927) und politisch (1934) nützte. Sodann geht es 2. um die Charakteristika dieser Ikonisierung. Sie stehen auch im Mittelpunkt der anschließenden Analyse des Umgangs der Nationalsozialisten mit Schulz nach 1930, an dessen Ende der Beschluss zur Liquidierung von Mythos und Person stand.' (Autorenreferat)'At the 30th of June 1934 ('Röhm-Putsch') the Nazi leaders also attempted to kill the 'Fememörder' Paul Schulz, although they had stylized him as a hero only several years before. After a startling criminal case in 1927, in which Paul Schulz had been sentenced to death due to the murder of 'betrayers' in the 'Schwarze Reichswehr' he was admitted - prior to his death - to a specific cult, which the Nazi 'movement' built around its 'dead heroes'. But in 1930 he was amnestied and had to be (re)integrated into the Nazi party - as a living 'dead hero'. This paper investigates the Schulz-myth, which - from that incident on - evolved into a remarkable life on its own, endangering the national socialists and their concept of 'martyrs'. Two aspects are in the focus of this investigation: 1. The 'Femeprozesse' and the questions who had an iconical (1927) and political (1934) interest in the corpse; furthermore the reasons behind this interest. 2. The characteristics of that iconification of Schulz intended by the Nazi propaganda as well as the problems evocing due to Schulz' survival after 1930 - finally ending in the decision to liquidate both, myth and personality.' (author's abstract

Orthoplastics in Periprosthetic Joint Infection of the Knee: Treatment Concept for Composite Soft-tissue Defect with Extensor Apparatus Deficiency.

Introduction: Reconstruction of composite soft-tissue defects with extensor apparatus deficiency in patients with periprosthetic joint infection (PJI) of the knee is challenging. We present a single-centre multidisciplinary orthoplastic treatment concept based on a retrospective outcome analysis over 20 years. Methods and Results: One-hundred sixty patients had PJI after total knee arthroplasty. Plastic surgical reconstruction of a concomitant perigenicular soft-tissue defect was indicated in 47 patients. Of these, six presented with extensor apparatus deficiency. One patient underwent primary arthrodesis and five patients underwent reconstruction of the extensor apparatus. The principle to reconstruct missing tissue 'like with like' was thereby favoured: Two patients with a wide soft-tissue defect received a free anterolateral thigh flap with fascia lata; one patient with a smaller soft-tissue defect received a free sensate, extended lateral arm flap with triceps tendon; and two patients who did not qualify for free flap surgery received a pedicled medial sural artery perforator gastrocnemius flap. Despite good functional results 1 year later, long-term follow-up revealed that two patients had to undergo arthrodesis because of recurrent infection and one patient was lost to follow-up. Conclusion: These results show that PJI of the knee and extensor apparatus deficiency is a dreaded combination with a poor long-term outcome. Standardization of surgical techniques for a defined PJI problem and consensus on study variables may facilitate interinstitutional comparisons of outcome data, and hence, improvement of treatment concepts

Observation of the hyperfine transition in lithium-like Bismuth 209Bi80+^{209}\text{Bi}^{80+}: Towards a test of QED in strong magnetic fields

We performed a laser spectroscopic determination of the $2s$ hyperfine splitting (HFS) of Li-like $^{209}\text{Bi}^{80+}$ and repeated the measurement of the $1s$ HFS of H-like $^{209}\text{Bi}^{82+}$. Both ion species were subsequently stored in the Experimental Storage Ring at the GSI Helmholtzzentrum f\"ur Schwerionenforschung Darmstadt and cooled with an electron cooler at a velocity of $\approx 0.71\,c$. Pulsed laser excitation of the $M1$ hyperfine-transition was performed in anticollinear and collinear geometry for $\text{Bi}^{82+}$ and $\text{Bi}^{80+}$, respectively, and observed by fluorescence detection. We obtain $\Delta E^{(1s)}= 5086.3(11)\,\textrm{meV}$ for $\text{Bi}^{82+}$, different from the literature value, and $\Delta E^{(2s)}= 797.50(18)\,\textrm{meV}$ for $\text{Bi}^{80+}$. These values provide experimental evidence that a specific difference between the two splitting energies can be used to test QED calculations in the strongest static magnetic fields available in the laboratory independent of nuclear structure effects. The experimental result is in excellent agreement with the theoretical prediction and confirms the sum of the Dirac term and the relativistic interelectronic-interaction correction at a level of 0.5% confirming the importance of accounting for the Breit interaction.Comment: 5 pages, 2 figure

The LIM-only protein FHL2 interacts with β-catenin and promotes differentiation of mouse myoblasts

FHL2 is a LIM-domain protein expressed in myoblasts but down-regulated in malignant rhabdomyosarcoma cells, suggesting an important role of FHL2 in muscle development. To investigate the importance of FHL2 during myoblast differentiation, we performed a yeast two-hybrid screen using a cDNA library derived from myoblasts induced for differentiation. We identified β-catenin as a novel interaction partner of FHL2 and confirmed the specificity of association by direct in vitro binding tests and coimmunoprecipitation assays from cell lysates. Deletion analysis of both proteins revealed that the NH2-terminal part of β-catenin is sufficient for binding in yeast, but addition of the first armadillo repeat is necessary for binding FHL2 in mammalian cells, whereas the presence of all four LIM domains of FHL2 is needed for the interaction. Expression of FHL2 counteracts β-catenin–mediated activation of a TCF/LEF-dependent reporter gene in a dose-dependent and muscle cell–specific manner. After injection into Xenopus embryos, FHL2 inhibited the β-catenin–induced axis duplication. C2C12 mouse myoblasts stably expressing FHL2 show increased myogenic differentiation reflected by accelerated myotube formation and expression of muscle-specific proteins. These data imply that FHL2 is a muscle-specific repressor of LEF/TCF target genes and promotes myogenic differentiation by interacting with β-catenin

Adherence to community versus facility-based delivery of monthly malaria chemoprevention with dihydroartemisinin-piperaquine for the post-discharge management of severe anemia in Malawian children: A cluster randomized trial

BACKGROUND The provision of post-discharge malaria chemoprevention (PMC) in children recently admitted with severe anemia reduces the risk of death and re-admissions in malaria endemic countries. The main objective of this trial was to identify the most effective method of delivering dihydroartemesinin-piperaquine to children recovering from severe anemia. METHODS This was a 5-arm, cluster-randomized trial among under-5 children hospitalized with severe anemia at Zomba Central Hospital in Southern Malawi. Children were randomized to receive three day treatment doses of dihydroartemesinin-piperaquine monthly either; 1) in the community without a short text reminder; 2) in the community with a short message reminder; 3) in the community with a community health worker reminder; 4) at the facility without a short text reminder; or 5) at the facility with a short message reminder. The primary outcome measure was adherence to all treatment doses of dihydroartemesinin-piperaquine and this was assessed by pill-counts done by field workers during home visits. Poisson regression was utilized for analysis. RESULTS Between March 2016 and October 2018, 1460 clusters were randomized. A total of 667 children were screened and 375 from 329 clusters were eligible and enrolled from the hospital. Adherence was higher in all three community-based compared to the two facility-based delivery (156/221 [70·6%] vs. 78/150 [52·0%], IRR = 1·24,95%CI 1·06-1·44, p = 0·006). This was observed in both the SMS group (IRR = 1·41,1·21-1·64, p<0·001) and in the non-SMS group (IRR = 1·37,1·18-1·61, p<0·001). Although adherence was higher among SMS recipients (98/148 66·2%] vs. non-SMS 82/144 (56·9%), there was no statistical evidence that SMS reminders resulted in greater adherence ([IRR = 1·03,0·88-1·21, p = 0·68). When compared to the facility-based non-SMS arm (control arm), community-based delivery utilizing CHWs resulted in higher adherence [39/76 (51·3%) vs. 54/79 (68·4%), IRR = 1·32, 1·14-1·54, p<0·001]. INTERPRETATION Community-based delivery of dihydroartemesinin-piperaquine for post-discharge malaria chemoprevention in children recovering from severe anemia resulted in higher adherence compared to facility-based methods. TRIAL REGISTRATION NCT02721420; ClinicalTrials.gov

Economic evaluation of postdischarge malaria chemoprevention in preschool children treated for severe anaemia in Malawi, Kenya, and Uganda: A cost-effectiveness analysis

Background Children hospitalised with severe anaemia in malaria-endemic areas are at a high risk of dying or being readmitted within six months of discharge. A trial in Kenya and Uganda showed that three months of postdischarge malaria chemoprevention (PDMC) with monthly dihydroartemisinin-piperaquine (DP) substantially reduced this risk. The World Health Organization recently included PDMC in its malaria chemoprevention guidelines. We conducted a cost-effectiveness analysis of community-based PDMC delivery (supplying all three PDMC-DP courses to caregivers at discharge to administer at home), facility-based PDMC delivery (monthly dispensing of PDMC-DP at the hospital), and the standard of care (no PDMC). Methods We combined data from two recently completed trials; one placebo-controlled trial in Kenya and Uganda collecting efficacy data (May 6, 2016 until November 15, 2018; n=1049), and one delivery mechanism trial from Malawi collecting adherence data (March 24, 2016 until October 3, 2018; n=375). Cost data were collected alongside both trials. Three Markov decision models, one each for Malawi, Kenya, and Uganda, were used to compute incremental cost-effectiveness ratios expressed as costs per quality-adjusted life-year (QALY) gained. Deterministic and probabilistic sensitivity analyses were performed to account for uncertainty. Findings Both PDMC strategies were cost-saving in each country, meaning less costly and more effective in increasing health-adjusted life expectancy than the standard of care. The estimated incremental cost savings for community-based PDMC compared to the standard of care were US$ 22·10 (Malawi), 38·52 (Kenya), and 26·23 (Uganda) per child treated. The incremental effectiveness gain using either PDMC strategy varied between 0·3 and 0·4 QALYs. Community-based PDMC was less costly and more effective than facility-based PDMC. These results remained robust in sensitivity analyses. Interpretation PDMC under implementation conditions is cost-saving. Caregivers receiving PDMC at discharge is a cost-effective delivery strategy for implementation in malaria-endemic southeastern African settings

Late-glacial and Holocene European pollen data

peerreview_statement: The publishing and review policy for this title is described in its Aims & Scope. aims_and_scope_url: http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=tjom2

Outbreak of Peste des Petits Ruminants Virus among Criticially Endangered Mongolian Saiga and Other Wild Ungulates, Mongolia, 2016-2017

The 2016–2017 introduction of peste des petits ruminants virus (PPRV) into livestock in Mongolia was followed by mass mortality of the critically endangered Mongolian saiga antelope and other rare wild ungulates. To assess the nature and population effects of this outbreak among wild ungulates, we collected clinical, histopathologic, epidemiologic, and ecological evidence. Molecular characterization confirmed that the causative agent was PPRV lineage IV. The spatiotemporal patterns of cases among wildlife were similar to those among livestock affected by the PPRV outbreak, suggesting spillover of virus from livestock at multiple locations and time points and subsequent spread among wild ungulates. Estimates of saiga abundance suggested a population decline of 80%, raising substantial concerns for the species’ survival. Consideration of the entire ungulate community (wild and domestic) is essential for elucidating the epidemiology of PPRV in Mongolia, addressing the threats to wild ungulate conservation, and achieving global PPRV eradication